{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:33:25Z","timestamp":1791200005629,"version":"4.2.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T00:00:00Z","timestamp":1470787200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T00:00:00Z","timestamp":1470787200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA158243"],"award-info":[{"award-number":["R01CA158243"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"crossref","award":["R21CA173263"],"award-info":[{"award-number":["R21CA173263"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007052","name":"Memorial Sloan Kettering Cancer Center","doi-asserted-by":"crossref","award":["P30-CA008748"],"award-info":[{"award-number":["P30-CA008748"]}],"id":[{"id":"10.13039\/100007052","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s10549-016-3939-0","type":"journal-article","created":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T09:47:28Z","timestamp":1470822448000},"page":"327-333","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":312,"title":["Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk"],"prefix":"10.1007","volume":"159","author":[{"given":"Ting","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coby","family":"Basal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Seluzicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan Q.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Seidman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun J.","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,10]]},"reference":[{"issue":"12","key":"3939_CR1","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/nrneurol.2010.160","volume":"6","author":"G Cavaletti","year":"2010","unstructured":"Cavaletti G, Marmiroli P (2010) Chemotherapy-induced peripheral neurotoxicity. Nat Rev Neurol 6(12):657\u2013666","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"3939_CR2","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.ctrv.2014.04.004","volume":"40","author":"NC Miltenburg","year":"2014","unstructured":"Miltenburg NC, Boogerd W (2014) Chemotherapy-induced neuropathy: a comprehensive survey. Cancer Treat Rev 40(7):872\u2013882","journal-title":"Cancer Treat Rev"},{"issue":"12","key":"3939_CR3","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","volume":"155","author":"M Seretny","year":"2014","unstructured":"Seretny M et al (2014) Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain 155(12):2461\u20132470","journal-title":"Pain"},{"issue":"3","key":"3939_CR4","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s10549-010-1278-0","volume":"125","author":"DL Hershman","year":"2011","unstructured":"Hershman DL et al (2011) Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy. Breast Cancer Res Treat 125(3):767\u2013774","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"3939_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ejca.2014.11.024","volume":"51","author":"L Eckhoff","year":"2015","unstructured":"Eckhoff L et al (2015) Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors. Eur J Cancer 51(3):292\u2013300","journal-title":"Eur J Cancer"},{"issue":"1","key":"3939_CR6","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s10147-011-0352-x","volume":"18","author":"Y Tanabe","year":"2013","unstructured":"Tanabe Y et al (2013) Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer. Int J Clin Oncol 18(1):132\u2013138","journal-title":"Int J Clin Oncol"},{"key":"3939_CR7","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/2193-1801-3-366","volume":"3","author":"B Bhatnagar","year":"2014","unstructured":"Bhatnagar B et al (2014) Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience. Springerplus 3:366","journal-title":"Springerplus"},{"issue":"5","key":"3939_CR8","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/cncr.22921","volume":"110","author":"A Badros","year":"2007","unstructured":"Badros A et al (2007) Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature. Cancer 110(5):1042\u20131049","journal-title":"Cancer"},{"issue":"4","key":"3939_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3727\/096504012X13522227232192","volume":"20","author":"K Kawakami","year":"2012","unstructured":"Kawakami K et al (2012) Factors exacerbating peripheral neuropathy induced by paclitaxel plus carboplatin in non-small cell lung cancer. Oncol Res 20(4):179\u2013185","journal-title":"Oncol Res"},{"key":"3939_CR10","doi-asserted-by":"crossref","unstructured":"Hershman DL et al.(2016) Comorbidities and risk of chemotherapy-induced peripheral neuropathy among participants 65 years or older in southwest oncology group clinical trials. J Clin Oncol","DOI":"10.1200\/JCO.2015.66.2346"},{"issue":"1","key":"3939_CR11","doi-asserted-by":"publisher","first-page":"R8","DOI":"10.1186\/bcr2813","volume":"13","author":"JJ Mao","year":"2011","unstructured":"Mao JJ et al (2011) Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors. Breast Cancer Res 13(1):R8","journal-title":"Breast Cancer Res"},{"issue":"1\u20132","key":"3939_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.pain.2005.01.028","volume":"115","author":"DC Zelman","year":"2005","unstructured":"Zelman DC et al (2005) Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy. Pain 115(1\u20132):29\u201336","journal-title":"Pain"},{"issue":"6","key":"3939_CR13","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.jpainsymman.2012.06.007","volume":"45","author":"WH Oldenmenger","year":"2013","unstructured":"Oldenmenger WH et al (2013) Cut points on 0\u201310 numeric rating scales for symptoms included in the edmonton symptom assessment scale in cancer patients: a systematic review. J Pain Symptom Manage 45(6):1083\u20131093","journal-title":"J Pain Symptom Manage"},{"issue":"6","key":"3939_CR14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361\u2013370","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"3939_CR15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/sleep\/34.5.601","volume":"34","author":"CM Morin","year":"2011","unstructured":"Morin CM et al (2011) The insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep 34(5):601\u2013608","journal-title":"Sleep"},{"issue":"5","key":"3939_CR16","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.ejpain.2006.08.001","volume":"11","author":"FM Blyth","year":"2007","unstructured":"Blyth FM et al (2007) Pain and falls in older people. Eur J Pain 11(5):564\u2013571","journal-title":"Eur J Pain"},{"issue":"9","key":"3939_CR17","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1111\/j.1532-5415.2005.53455.x","volume":"53","author":"SE Lamb","year":"2005","unstructured":"Lamb SE et al (2005) Development of a common outcome data set for fall injury prevention trials: the prevention of falls network Europe consensus. J Am Geriatr Soc 53(9):1618\u20131622","journal-title":"J Am Geriatr Soc"},{"key":"3939_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1200\/JCO.2015.63.2489","volume":"34","author":"KM Winters-Stone","year":"2016","unstructured":"Winters-Stone KM, Hilton C, Luoh S-W, Jacobs P, Faithfull S, Horak FB (2016) Comparison of physical function and falls among women with persistent symptoms of chemotherapy-induced peripheral neuropathy. J Clin Oncol 34:130","journal-title":"J Clin Oncol"},{"issue":"22","key":"3939_CR19","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.1158\/1078-0432.CCR-15-0586","volume":"21","author":"BP Schneider","year":"2015","unstructured":"Schneider BP et al (2015) Genome-wide association studies for taxane-induced peripheral neuropathy in ECOG-5103 and ECOG-1199. Clin Cancer Res 21(22):5082\u20135091","journal-title":"Clin Cancer Res"},{"issue":"25","key":"3939_CR20","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1200\/JCO.2011.39.8446","volume":"30","author":"BP Schneider","year":"2012","unstructured":"Schneider BP et al (2012) Neuropathy is not associated with clinical outcomes in patients receiving adjuvant taxane-containing therapy for operable breast cancer. J Clin Oncol 30(25):3051\u20133057","journal-title":"J Clin Oncol"},{"issue":"17","key":"3939_CR21","doi-asserted-by":"publisher","first-page":"7603","DOI":"10.7314\/APJCP.2015.16.17.7603","volume":"16","author":"A Shahriari-Ahmadi","year":"2015","unstructured":"Shahriari-Ahmadi A et al (2015) Prevalence of oxaliplatin-induced chronic neuropathy and influencing factors in patients with colorectal cancer in Iran. Asian Pac J Cancer Prev 16(17):7603\u20137606","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"3939_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000442527","volume":"90","author":"A Ottaiano","year":"2016","unstructured":"Ottaiano A et al (2016) Diabetes and body mass index are associated with neuropathy and prognosis in colon cancer patients treated with capecitabine and oxaliplatin adjuvant chemotherapy. Oncology 90(1):36\u201342","journal-title":"Oncology"},{"issue":"1\u20132","key":"3939_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1900\/RDS.2015.12.48","volume":"12","author":"N Papanas","year":"2015","unstructured":"Papanas N, Ziegler D (2015) Risk factors and comorbidities in diabetic neuropathy: an update 2015. Rev Diabet Stud 12(1\u20132):48\u201362","journal-title":"Rev Diabet Stud"},{"issue":"1","key":"3939_CR24","first-page":"60","volume":"18","author":"AG Smith","year":"2012","unstructured":"Smith AG, Singleton JR (2012) Diabetic neuropathy. Continuum (Minneap Minn) 18(1):60\u201384","journal-title":"Continuum (Minneap Minn)"},{"issue":"4","key":"3939_CR25","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.metabol.2005.11.004","volume":"55","author":"J Verbraecken","year":"2006","unstructured":"Verbraecken J et al (2006) Body surface area in normal-weight, overweight, and obese adults. A comparison study. Metabolism 55(4):515\u2013524","journal-title":"Metabolism"},{"issue":"18","key":"3939_CR26","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1158\/1078-0432.CCR-12-1590","volume":"18","author":"RM Baldwin","year":"2012","unstructured":"Baldwin RM et al (2012) A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101. Clin Cancer Res 18(18):5099\u20135109","journal-title":"Clin Cancer Res"},{"issue":"9","key":"3939_CR27","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1158\/1078-0432.CCR-13-3232","volume":"20","author":"JE Abraham","year":"2014","unstructured":"Abraham JE et al (2014) Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with paclitaxel. Clin Cancer Res 20(9):2466\u20132475","journal-title":"Clin Cancer Res"},{"issue":"2","key":"3939_CR28","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1158\/1078-0432.CCR-14-1758","volume":"21","author":"M Apellaniz-Ruiz","year":"2015","unstructured":"Apellaniz-Ruiz M et al (2015) Whole-exome sequencing reveals defective CYP3A4 variants predictive of paclitaxel dose-limiting neuropathy. Clin Cancer Res 21(2):322\u2013328","journal-title":"Clin Cancer Res"},{"issue":"6","key":"3939_CR29","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/annonc\/mdt018","volume":"24","author":"DL Hertz","year":"2013","unstructured":"Hertz DL et al (2013) CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel. Ann Oncol 24(6):1472\u20131478","journal-title":"Ann Oncol"},{"issue":"4","key":"3939_CR30","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/tpj.2014.2","volume":"14","author":"A Chhibber","year":"2014","unstructured":"Chhibber A et al (2014) Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance). Pharmacogenomics J 14(4):336\u2013342","journal-title":"Pharmacogenomics J"},{"issue":"5","key":"3939_CR31","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/ana.24265","volume":"76","author":"AS Beutler","year":"2014","unstructured":"Beutler AS et al (2014) Sequencing of charcot-marie-tooth disease genes in a toxic polyneuropathy. Ann Neurol 76(5):727\u2013737","journal-title":"Ann Neurol"},{"issue":"1","key":"3939_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1529-8027.2008.00156.x","volume":"13","author":"AJ Windebank","year":"2008","unstructured":"Windebank AJ, Grisold W (2008) Chemotherapy-induced neuropathy. J Peripher Nerv Syst 13(1):27\u201346","journal-title":"J Peripher Nerv Syst"},{"issue":"3","key":"3939_CR33","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.pain.2009.02.001","volume":"142","author":"XM Wang","year":"2009","unstructured":"Wang XM et al (2009) Upregulation of IL-6, IL-8 and CCL2 gene expression after acute inflammation: correlation to clinical pain. Pain 142(3):275\u2013283","journal-title":"Pain"},{"issue":"2","key":"3939_CR34","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","volume":"71","author":"MB Howren","year":"2009","unstructured":"Howren MB, Lamkin DM, Suls J (2009) Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71(2):171\u2013186","journal-title":"Psychosom Med"},{"issue":"5","key":"3939_CR35","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1210\/jcem.82.5.3950","volume":"82","author":"AN Vgontzas","year":"1997","unstructured":"Vgontzas AN et al (1997) Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 82(5):1313\u20131316","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"3939_CR36","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1532-5415.2005.00642.x","volume":"54","author":"R von Kanel","year":"2006","unstructured":"von Kanel R et al (2006) Poor sleep is associated with higher plasma proinflammatory cytokine interleukin-6 and procoagulant marker fibrin D-dimer in older caregivers of people with alzheimer\u2019s disease. J Am Geriatr Soc 54(3):431\u2013437","journal-title":"J Am Geriatr Soc"},{"issue":"1\u20132","key":"3939_CR37","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.psychres.2015.06.036","volume":"229","author":"P Pallavi","year":"2015","unstructured":"Pallavi P et al (2015) Serum cytokines and anxiety in adolescent depression patients: gender effect. Psychiatry Res 229(1\u20132):374\u2013380","journal-title":"Psychiatry Res"},{"issue":"3","key":"3939_CR38","doi-asserted-by":"publisher","first-page":"e0121971","DOI":"10.1371\/journal.pone.0121971","volume":"10","author":"FM Schmidt","year":"2015","unstructured":"Schmidt FM et al (2015) Inflammatory cytokines in general and central obesity and modulating effects of physical activity. PLoS One 10(3):e0121971","journal-title":"PLoS One"},{"issue":"7","key":"3939_CR39","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1007\/s00520-013-1766-y","volume":"21","author":"JS Gewandter","year":"2013","unstructured":"Gewandter JS et al (2013) Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of rochester CCOP study. Support Care Cancer 21(7):2059\u20132066","journal-title":"Support Care Cancer"},{"issue":"3","key":"3939_CR40","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00520-011-1127-7","volume":"20","author":"C Tofthagen","year":"2012","unstructured":"Tofthagen C, Overcash J, Kip K (2012) Falls in persons with chemotherapy-induced peripheral neuropathy. Support Care Cancer 20(3):583\u2013589","journal-title":"Support Care Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3939-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-016-3939-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3939-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T12:50:48Z","timestamp":1589719848000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-016-3939-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,10]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["3939"],"URL":"https:\/\/doi.org\/10.1007\/s10549-016-3939-0","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,10]]},"assertion":[{"value":"26 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.Experiments comply with the current laws of the United States.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}